Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EWTX | AMGN | VRTX | REGN | BMY |
| Company | Edgewise Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.29 | 315.28 | 442.00 | 969.27 | 44.30 |
| High | 18.29 | 315.28 | 444.53 | 980.30 | 44.30 |
| Low | 17.42 | 310.37 | 440.35 | 966.00 | 43.73 |
| Last | 17.92 | 312.15 | 444.90 | 978.04 | 44.13 |
| Change | -0.26 | -2.57 | +4.26 | +10.06 | +0.02 |
| % Change | -1.43% | -0.82% | +0.97% | +1.04% | +0.05% |
| Volume | 276,629 | 1,087,188 | 532,306 | 212,819 | 7,568,036 |
| 20-Day Average Volume | 705,558 | 2,862,893 | 1,078,633 | 446,245 | 14,536,220 |
| Previous Close | 18.18 | 314.72 | 440.64 | 967.98 | 44.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.06 | 293.56 | 412.35 | 939.12 | 45.04 |
| 20-Day Raw Stochastic | 45.07% | 81.73% | 98.99% | 91.54% | 11.76% |
| 20-Day Relative Strength | 51.47% | 63.55% | 71.62% | 60.43% | 33.98% |
| Weighted Alpha | +78.23 | +38.68 | +32.61 | +30.31 | -34.20 |
| Today's Opinion | 88% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 40% Buy | 56% Sell | 8% Buy | 24% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.24% since 05/10/24 | +0.66% since 05/10/24 | +5.00% since 05/10/24 | +0.57% since 05/10/24 | -1.95% since 05/10/24 |
| Low | 17.05 on 05/14/24 | 307.06 on 05/13/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 43.68 on 05/16/24 |
| High | 18.57 on 05/13/24 | 321.44 on 05/15/24 | 444.47 on 05/17/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +14.50% since 04/17/24 | +18.23% since 04/17/24 | +12.93% since 04/17/24 | +8.67% since 04/17/24 | -7.89% since 04/17/24 |
| Low | 14.90 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 21.60 on 05/08/24 | 322.60 on 05/03/24 | 444.47 on 05/17/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +3.17% since 02/16/24 | +10.05% since 02/16/24 | +5.15% since 02/16/24 | +3.30% since 02/16/24 | -11.62% since 02/16/24 |
| Low | 14.90 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 21.60 on 05/08/24 | 322.60 on 05/03/24 | 444.47 on 05/17/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +180.44% since 11/17/23 | +17.64% since 11/17/23 | +26.66% since 11/17/23 | +22.05% since 11/17/23 | -13.33% since 11/17/23 |
| Low | 5.93 on 12/01/23 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 43.33 on 05/02/24 |
| High | 21.60 on 05/08/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,697,994 | 168,826,816 | 113,708,480 | 106,657,832 | 89,415,376 |
| Shares Outstanding, K | 93,399 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -100,160,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -28,530,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.15 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.13 | 29.05 | 26.36 | 42.43 |